Abstract Natural killer (NK) cell-based immunotherapy has become a research focus in cellular immunotherapy in recent years,which has advanced rapidly in the treatment of solid tumors. NK cells are key effector cells of innate immunity and can kill abnormal target cells without prior sensitization. A broad consensus holds that NK cell-based immunotherapy may become a new strategy for solid tumor treatment with lower risk and lower cost than T-cell-based immunotherapy.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Juntong
Contact Juntong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack